Firms

Kineticos Life Sciences

Kineticos Life Sciences

Raleigh, North Carolina, United States

kineticos.com

Kineticos Life Sciences is a Raleigh, North Carolina life-sciences growth-equity and venture investment platform with roots in strategic consulting. Its current legal investment adviser is Kineticos Life Sciences Management LLC, CRD 318515, according to its March 26, 2026 Form ADV; the associated Kineticos Ventures LLC is named as a manager and general-partner affiliate in SEC fund filings and the firm’s own team descriptions. Those related legal entities are qualified within the platform profile, rather than treated as unrelated investors or confused with Kinetic Ventures, Horizon Kinetics, Kinetic Automation or Global Kinetics Corporation. The firm invests in pharma services, life-science tools, equipment and novel therapeutics through its Disruptor, AMR Accelerator and Capital Partners strategies. Its Disruptor series has operated since 2019, targeting oncology, neurodegenerative and rare diseases; the AMR strategy addresses antimicrobial resistance. Relevant portfolio exposure includes neuro42’s portable brain MRI, robotics and AI platform, Promaxo’s modular MRI systems and Amylyx’s neurodegenerative therapeutics. Published portfolio descriptions do not establish individual advisers’ cash investments. The current public directory lists eight core investment professionals, nine venture and operating partners and ten strategic advisers; external career titles are published background rather than independently asserted current corporate appointments. Disruptor Fund II closed exactly USD57.3 million in committed capital, announced November 17, 2023; the headline’s approximately USD60 million is rounded. Other fund/SPV gross asset values, offering targets and company financing amounts are not reported as fund closing sizes.

Founded
—
Type
Venture capital

Funds14

  • KINETICOS DISRUPTOR FUND II, L.P.$57M
  • KINETICOS 2024 KINCELL CO-INVESTMENT FUND, LLC—
  • KINETICOS 2025 KINCELL CO-INVESTMENT FUND, LLC—
  • KINETICOS AMR ACCELERATOR FUND I, L.P.—
  • KINETICOS DISRUPTOR FUND EB9, LLC—
  • KINETICOS DISRUPTOR FUND FB5, LLC—
  • KINETICOS DISRUPTOR FUND IB4, LLC—
  • KINETICOS DISRUPTOR FUND IB8, LLC—

Team

Operations and support

Abe MaingiAbe MaingiVenture and Operating Partner
Afshin SafaviAfshin SafaviVenture and Operating Partner
Andrew HokeAndrew HokeAnalyst
Bruce ThompsonBruce ThompsonStrategic Advisor
Chris HeeryChris HeeryStrategic Advisor
Dan McCormickDan McCormickStrategic Advisor
Dave OusteroutDave OusteroutStrategic Advisor
David KingDavid KingStrategic Advisor
Derek HenneckeDerek HenneckeVenture and Operating Partner
Dilán RiveraDilán RiveraSenior Analyst
Douglas ThomsonDouglas ThomsonVenture and Operating Partner
Frank LisFrank LisGeneral Partner
Geordan DavisGeordan DavisAnalyst
George FotiadesGeorge FotiadesVenture and Operating Partner
John BallantyneJohn BallantyneVenture and Operating Partner
Keith CapecciKeith CapecciPrincipal
Marc WolffMarc WolffVenture and Operating Partner
Mark BamforthMark BamforthKAMRA I Investment Committee Member
Mark GilbertMark GilbertStrategic Advisor
Michael ChambersMichael ChambersVenture and Operating Partner
Michael W. BonneyMichael W. BonneyStrategic Advisor
Mike NicholsonMike NicholsonPrincipal; Strategic Advisor (directory category)
Nathan FingerNathan FingerStrategic Advisor
Nigel WalkerNigel WalkerVenture and Operating Partner
Richard SnyderRichard SnyderKAMRA I Investment Committee Member
Shailesh MaingiShailesh MaingiFounder, Managing Partner
Steve FavaloroSteve FavaloroStrategic Advisor

Co-investing

No co-investors on record yet.

Investments